hotspot
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
Next article: Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
explore
knowledge
-
Louisiana bill approved classifying abortion pills as controlled substances
2025-09-28 21:06 -
Eli Lilly to pay $200M for Beam’s stake in gene
2025-09-28 20:59 -
The FDA weighs the risks of candy
2025-09-28 19:54 -
Clinicians often fail to acknowledge the pain caused by long Covid
2025-09-28 19:11 -
J&J reports mixed data on next
2025-09-28 19:01 -
Maker of FluMist seeks to allow at
2025-09-28 18:57